It's not just marketing.. dose monitoring and treatment efficacy in traditional chemotherapy has been an ongoing problem since the beginning. This is especially problematic when the basis for chemotherapy is, well, killing cells. Current imaging techniques are ill suited for continual monitoring - either because of cost or further radiation damage.
Siemens and Sirtex, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
0.003(1.92%) |
Mkt cap ! $57.30M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 14.0¢ | 13.0¢ | $148.0K | 1.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 548006 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 824793 | 16 |
View Market Depth
| Last trade - 15.50pm 27/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |